A Multi-Center, phase 1/2 Trial of AlloNK® Cell Therapy ± Rituximab in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Umar Farooq, Amitkumar Mehta, Erin A. Dean, Jennifer N. Saultz, Joseph J. Maly, Bassam Ibrahim Mattar, Adam J. Olszewski, Ruthee L. Bayer, Gina Chu, Gilad Gordon, Heather Kelley, Feng Xu
+3 more Heather K. Raymon, Thorsten T. Graef, Rashmi Khanal
DOI: 10.1016/j.jtct.2025.12.535
Cited by: 0

Fields of Study & Subjects

Immune Cell Function and Interaction CAR-T cell therapy research Lymphoma Diagnosis and Treatment

Publication details

Journal / source
Transplantation and Cellular Therapy
Volume
32
Issue
2
Pages
S372–S372
Publication date
1 February 2026
Language
EN